Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00195286

Enrollment

180

Registered

2005-09-19

Start date

2004-06-30

Completion date

2007-07-31

Last updated

2009-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Infections

Keywords

Urinary Infections

Brief summary

The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections

Interventions

DRUGpiperacillin/tazobactam

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* Hospitalized patients over 16 years of age with complicated urinary infection produced by bacteria that are suspected to be susceptible to treatment with Piperacillin-tazobactam.

Exclusion criteria

* Patients known, or thought to be hypersensitivity to beta-lactams * Patients with an uncomplicated urinary tract infection

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026